Toyoaki Hida
Department of Internal Medicine
Aichi Cancer Center Hospital
Nagoya 464-8681
Japan
Name/email consistency: low
- Gefitinib for the treatment of non-small-cell lung cancer. Hida, T., Ogawa, S., Park, J.C., Park, J.Y., Shimizu, J., Horio, Y., Yoshida, K. Expert. Rev. Anticancer. Ther (2009)
- Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. Hida, T., Kozaki, K., Ito, H., Miyaishi, O., Tatematsu, Y., Suzuki, T., Matsuo, K., Sugiura, T., Ogawa, M., Takahashi, T., Takahashi, T. Clin. Cancer Res. (2002)